Patent · US Active

Inhibitors of C5a for the treatment of viral pneumonia

US10227397B2 · kind B2 · utility

1Cited by
0References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 20, 2015
Grant dateMar 12, 2019
Priority date
Expiry dateMar 20, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to inhibitors of C5a for use in the treatment of pneumonia, especially viral pneumonia. The invention also relates to the use of inhibitors of C5a in the preparation of a pharmaceutical composition for the treatment of pneumonia, especially viral pneumonia. The inventors further relates to methods for the treatment of pneumonia, especially viral pneumonia, comprising the step of administering a therapeutic amount of an inhibitor of C5a to a subject in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.